Libutti SK - Search Results

1

Monitoring responses to antiangiogenic agents using noninvasive imaging tests.

Libutti SK, Choyke P, Carrasquillo JA, Bacharach S, Neumann RD. Libutti SK, et al. Cancer J Sci Am. 1999 Sep-Oct;5(5):252-6. Cancer J Sci Am. 1999. PMID: 10526663 Review. No abstract available.

2

Special techniques for imaging blood flow to tumors.

Choyke PL, Knopp MV, Libutti SK. Choyke PL, et al. Among authors: libutti sk. Cancer J. 2002 Mar-Apr;8(2):109-18. doi: 10.1097/00130404-200203000-00005. Cancer J. 2002. PMID: 11999945 Review.

3

Parametric images of blood flow in oncology PET studies using [15O]water.

Lodge MA, Carson RE, Carrasquillo JA, Whatley M, Libutti SK, Bacharach SL. Lodge MA, et al. Among authors: libutti sk. J Nucl Med. 2000 Nov;41(11):1784-92. J Nucl Med. 2000. PMID: 11079484 Free article.

4

Measuring tumor blood flow with H(2)(15)O: practical considerations.

Bacharach SL, Libutti SK, Carrasquillo JA. Bacharach SL, et al. Among authors: libutti sk. Nucl Med Biol. 2000 Oct;27(7):671-6. doi: 10.1016/s0969-8051(00)00136-0. Nucl Med Biol. 2000. PMID: 11091110 Review.

5

Noise reduction in oncology FDG PET images by iterative reconstruction: a quantitative assessment.

Riddell C, Carson RE, Carrasquillo JA, Libutti SK, Danforth DN, Whatley M, Bacharach SL. Riddell C, et al. Among authors: libutti sk. J Nucl Med. 2001 Sep;42(9):1316-23. J Nucl Med. 2001. PMID: 11535719 Free article.

6

A prospective study of 2-[18F] fluoro-2-deoxy-D-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels.

Libutti SK, Alexander HR Jr, Choyke P, Bartlett DL, Bacharach SL, Whatley M, Jousse F, Eckelman WC, Kranda K, Neumann RD, Carrasquillo JA. Libutti SK, et al. Ann Surg Oncol. 2001 Dec;8(10):779-86. doi: 10.1007/s10434-001-0779-9. Ann Surg Oncol. 2001. PMID: 11776491

7

8:45-9:00. Using PET 18F-FDG, 11CO, and 15O-water for Monitoring Prostate Cancer During a Phase II Anti-angiogenic Drug Trial with Thalidomide.

Kurdziel K, Bacharach S, Carrasquillo J, Huebsch S, Whatley M, Sellers D, Steinberg S, Libutti S, Pluda J, Reed E, Dahut W, Figg W. Kurdziel K, et al. Clin Positron Imaging. 2000 Jul;3(4):144. doi: 10.1016/s1095-0397(00)00056-x. Clin Positron Imaging. 2000. PMID: 11150747

8

Current advances in molecular imaging: noninvasive in vivo bioluminescent and fluorescent optical imaging in cancer research.

Choy G, Choyke P, Libutti SK. Choy G, et al. Among authors: libutti sk. Mol Imaging. 2003 Oct;2(4):303-12. doi: 10.1162/15353500200303142. Mol Imaging. 2003. PMID: 14717329 Review.

9

Simplified kinetic analysis of tumor 18F-FDG uptake: a dynamic approach.

Sundaram SK, Freedman NM, Carrasquillo JA, Carson JM, Whatley M, Libutti SK, Sellers D, Bacharach SL. Sundaram SK, et al. Among authors: libutti sk. J Nucl Med. 2004 Aug;45(8):1328-33. J Nucl Med. 2004. PMID: 15299057 Free article. Clinical Trial.

10

Gadolinium-enhanced 3D MRA prior to isolated hepatic perfusion for metastases.

Zeh H, Choyke PL, Alexander HR, Bartlett DL, Libutti SK, Chang R, Summers RM. Zeh H, et al. Among authors: libutti sk. J Comput Assist Tomogr. 1999 Sep-Oct;23(5):664-9. doi: 10.1097/00004728-199909000-00003. J Comput Assist Tomogr. 1999. PMID: 10524842

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

327 results

Search Page

Filters